OU
Oxford University Innovation
Venture CapitalActiveOxford University Innovation manages the universityвАЩs technology transfer and consulting activities.
55
Investments
3
Exits
—
AUM
5.5%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Oxford University Innovation.
Investment Thesis & Strategy
Oxford University Innovation invests in various stages of companies, with a focus on fintech and consulting, leveraging its technology transfer and consulting expertise.
Investment Activity
Deals per year over the last 8 years
1
20141
20152
20163
20172
20180
20191
20202
2021Portfolio Companies
Selected investments from their portfolio of 55 companies
P
Proxima Concepts
Other · Seed, 2021
O
Osler Diagnostics
Healthcare · Series A, 2021
B
Baseimmune
Biotech · Seed, 2020
P
PepGen
Biotech · Series A, 2018
D
DJS Antibodies
Biotech · Series A, 2018
E
Evox Therapeutics
Biotech · Series B, 2017
O
Oxeia Biopharmaceuticals
Biotech · Series A, 2017
R
ReViral
Biotech · Series B, 2017
B
Brainomix
Healthcare · Series A, 2016
V
Vaccitech
Biotech · Series B, 2016
N
Navenio
Healthcare · Series A, 2015
C
Celleron Therapeutics
Biotech · Series A, 2014
Notable Exits
CompanyTypeYearValue / Acquirer
OxSonicsAcquisition2023—
VaccitechIPO2021$110M
Nightstar TherapeuticsAcquisition2019$855M
Frequently Asked Questions
Oxford University Innovation focuses on Series A, Series B, Series C+ stage investments.
Related Investors
Oxford Capital Partners
Oxford, United Kingdom · 170 deals
Oxford Technology Management
Oxford, United Kingdom · 121 deals
Oxford Sciences Innovation
Oxford, United Kingdom · 84 deals
Seven Spires Investment
Oxford, United Kingdom · 11 deals
Rockley Group
Oxford, United Kingdom · 4 deals
H2O Venture Partners
Oxford, United Kingdom · 2 deals